Flavonoid Supplementation Is Beneficial for Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis

CONTEXT: Polycystic ovary syndrome (PCOS) is a prevalent hormonal imbalance that predominantly affects women in their reproductive years. Previous studies have yielded conflicting conclusions. OBJECTIVE: This is an updated meta-analysis aiming to explore the connection between flavonoid supplementation and PCOS. DATA SOURCES: Seven databases were searched: Cochrane Library, PubMed, Web of Science, Embase, Wanfang, China Science and Technology Journal, and China National Knowledge Infrastructure, spanning from their inception to April 15, 2024. DATA EXTRACTION: Two authors independently searched the databases using the search terms. DATA ANALYSIS: Following strict inclusion criteria, 8 papers were ultimately included. This updated meta-analysis suggests that flavonoid supplementation could enhance follicular development, promote the proliferation and differentiation of follicular granulosa cells, elevate estradiol levels, and mitigate testosterone, C-reactive protein, and ovarian index levels. CONCLUSION: This analysis suggests that dietary flavonoids could potentially alleviate symptoms associated with PCOS. SYSTEMATIC REVIEW REGISTRATION: PROSPERO registration no. CRD42022382912.